Mielodiszplasztikus szindróma (MDS): vizsgálatok itt: Norvégia
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 17.. Ask the study team whether a trial fits you.
- 3. fázisTaking peoplePhase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
- Where
- Bergen, Oslo, Stavanger, Tromso, Trondheim
- Életkor
- 18 év to 75 év
- People
- 650 worldwide
- Run by
- University of Ulm
See details and how to joinNCT04628026 · EU 2023-507518-28-00 - 3. fázisNot yet taking people in NorvégiaA Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
- Where
- Bergen, Oslo, Toensberg
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Takeda
See details and how to joinNCT07422480 · EU 2025-523544-12-00 - 3. fázisTaking peopleLisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
- Where
- Bergen, Oslo, Skien, Tromsoe
- Életkor
- 18 év and over
- People
- 490 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06641414 · EU 2024-517247-31-00 - 2. fázisFut, nem toboroz(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - 2. fázisTaking peopleNMDSG-14B2
- Where
- Bergen, Oslo
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Karolinska University Hospital
See details and how to join2024-511651-17-00 - 1/2. fázisTaking peopleA Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients
- Where
- Bergen, Trondheim
- Életkor
- 18 év and over
- People
- 48
- Run by
- Haukeland University Hospital
See details and how to joinNCT06199557 · EU 2022-501992-15-00 - 2. fázisTaking peoplePrecision Therapy Versus Standard Therapy in AML and MDS in Elderly
- Where
- Lørenskog
- Életkor
- 60 év and over
- People
- 36
- Run by
- University Hospital, Akershus
See details and how to joinNCT05025098